Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SWAV Shockwave Medical (SWAV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends About Shockwave Medical Stock (NASDAQ:SWAV) 30 days 90 days 365 days Advanced Chart Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Key Stats Today's Range$334.75▼$334.7550-Day Range$328.87▼$334.8352-Week Range$157.00▼$334.90VolumeN/AAverage Volume968,088 shsMarket Capitalization$12.57 billionP/E Ratio78.21Dividend YieldN/APrice Target$309.11Consensus RatingHold Company OverviewShockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More… Central Bank Abandons USD (Ad)Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Shockwave Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 39th PercentileShockwave Medical scored higher than 39% of companies evaluated by MarketBeat, and ranked 773rd out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingShockwave Medical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 1 buy rating, 10 hold ratings, and no sell ratings.Amount of Analyst CoverageShockwave Medical has received no research coverage in the past 90 days.Read more about Shockwave Medical's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth21.98% Earnings GrowthEarnings for Shockwave Medical are expected to grow by 21.98% in the coming year, from $5.05 to $6.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.51.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 147.31.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 16.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SWAV. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Sustainability and ESG4.6 / 5Environmental Score-0.55 Short InterestThere is no current short interest data available for SWAV. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Shockwave Medical this week, compared to 5 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions95.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Shockwave Medical's insider trading history. SWAV Stock News HeadlinesJ&J’s Shockwave strengths IVL grasp with new US catheter launchSeptember 17 at 6:14 AM | msn.comNew noninvasive technique provides effective treatment for urinary stonesSeptember 12, 2024 | msn.comCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. September 19, 2024 | True Gold Republic (Ad)Balancing Growth and Challenges: A Hold Rating for Johnson & Johnson’s Medtech Division Amidst China HeadwindsSeptember 6, 2024 | markets.businessinsider.comBaird Q2 2024 Small/Mid Cap Growth Equity Fund CommentaryAugust 22, 2024 | seekingalpha.comIntroducing OMNIWave(TM): Revolutionizing Treatment with Advanced Shockwave Technology and Comprehensive Business SolutionsAugust 15, 2024 | markets.businessinsider.comGRPM: Why This Mid-Cap GARP ETF Deserves An UpgradeAugust 2, 2024 | seekingalpha.comJohn Hussman's Strategic Moves: A Deep Dive into His Q2 2024 Portfolio AdjustmentsAugust 1, 2024 | finance.yahoo.comSee More Headlines SWAV Stock Analysis - Frequently Asked Questions How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) announced its earnings results on Monday, May, 6th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.99 by $0.45. The company's revenue was up 35.8% on a year-over-year basis. When did Shockwave Medical IPO? Shockwave Medical (SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. Who are Shockwave Medical's major shareholders? Shockwave Medical's top institutional shareholders include Sanctuary Advisors LLC (0.01%), Blue Trust Inc., Cubist Systematic Strategies LLC and Point72 Asset Management L.P.. Insiders that own company stock include Frederic H Moll, Douglas Evan Godshall, Isaac Zacharias, Trinh Phung, Dan Puckett, Antoine Papiernik, Maria Sainz, Frank T Watkins, Sara Toyloy and Laura Francis. View institutional ownership trends. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU) and PayPal (PYPL). Company Calendar Last Earnings5/06/2024Today9/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,468Year FoundedN/APrice Target and Rating Average Stock Price Target$309.11 High Stock Price Target$368.00 Low Stock Price Target$210.00 Potential Upside/Downside-7.7%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$4.28 Trailing P/E Ratio78.21 Forward P/E Ratio66.29 P/E Growth2.43Net Income$147.28 million Net Margins20.75% Pretax Margin23.29% Return on Equity24.79% Return on Assets11.95% Debt Debt-to-Equity Ratio0.97 Current Ratio13.81 Quick Ratio12.61 Sales & Book Value Annual Sales$787.97 million Price / Sales15.95 Cash Flow$4.31 per share Price / Cash Flow77.61 Book Value$20.02 per share Price / Book16.72Miscellaneous Outstanding Shares37,544,000Free Float36,268,000Market Cap$12.57 billion OptionableOptionable Beta0.88 This page (NASDAQ:SWAV) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Shockwave Medical, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Shockwave Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.